GSA Capital Partners’s Immunic IMUX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-52,746
Closed -$282K 1931
2025
Q4
$282K Buy
52,746
+33,454
+173% +$245K 0.02% 1206
2025
Q3
$170K Buy
+19,292
New +$170K 0.01% 1463
2025
Q2
Sell
-17,738
Closed -$193K 1931
2025
Q1
$193K Buy
17,738
+6,144
+53% +$66.3K 0.02% 1402
2024
Q4
$116K Buy
11,594
+8,317
+254% +$105K 0.01% 1501
2024
Q3
$54K Sell
3,277
-8,400
-72% -$120K ﹤0.01% 1519
2024
Q2
$130K Buy
+11,677
New +$145K 0.01% 1505
2023
Q1
Sell
-7,919
Closed -$111K 1684
2022
Q4
$111K Buy
7,919
+4,947
+166% +$135K 0.01% 1293
2022
Q3
$94K Buy
+2,972
New +$124K 0.01% 1369
2019
Q2
Sell
-1,009
Closed -$80K 1574
2019
Q1
$80K Buy
1,009
+877
+664% +$77K 0.01% 1343
2018
Q4
$10K Buy
+132
New +$15.5K ﹤0.01% 1290

Other funds holding IMUX